Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Novartis    NOVN   CH0012005267

NOVARTIS

(NOVN)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Novartis
Novartis is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by family of products as follows:

- pharmaceutical products (67.2%): used to treat cardiovascular, respiratory, and dermatological diseases, gastrointestinal disorders, cancers, central nervous system disorders, hormone imbalances, etc.;

- generic drugs (20.5%; Sandoz);

- eye care products (12.3%; Alcon): eye drops and eye ointments, lens care products and ophthalmic surgery products.

Net sales break down geographically as follows: Switzerland (1.7%), Europe (33.9%), the United States (34.5%), Americas (8.1%) and Asia/Africa/Australasia (21.8%).

Number of employees : 125 161 people.
Sales per Businesses
20172018Delta
CHF (in Million)%CHF (in Million)%
Innovative Medicines32,50567.2%34,14867.2% +5.05%
Sandoz9,90220.5%9,64919% -2.56%
Alcon5,92912.3%6,99613.8% +18%
Sales per Regions
20172018Delta
CHF (in Million)%CHF (in Million)%
Other20,49342.4%21,69642.7% +5.87%
United States16,66934.5%17,18533.8% +3.1%
Germany3,6327.5%4,0958.1% +12.74%
Japan3,1276.5%3,1016.1% -0.82%
France2,4515.1%2,6475.2% +8.02%
United Kingdom1,1422.4%1,2342.4% +8.09%
Switzerland822.841.7%833.821.6% +1.33%
Managers
NameAgeSinceTitle
Vasant Narasimhan432005Chief Executive Officer
Jörg Reinhardt632013Independent Non-Executive Chairman
Harry Werner Kirsch542003Chief Financial Officer
John Tsai, MD522018Chief Medical Officer
Srikant T. Madhav Datar, PhD652003Independent Non-Executive Director
Andreas von Planta, PhD642006Independent Non-Executive Director
Ann Marie Fudge, MBA682008Independent Non-Executive Director
Enrico Cipro Vanni PhD, MBA682011Vice Chairman
Dimitri Azar MD, EMBA602012Independent Non-Executive Director
Charles L. Sawyers, MD602013Independent Non-Executive Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Stock A 1 2,527,374,820 2,208,661,981 87.4% 227,796,874 9.0% 87.4%
Shareholders
NameEquities%
Novartis AG 97,969,738 3.84%
Sandoz Family Foundation 88,972,723 3.49%
Novartis Foundation For Employee Participation 65,421,120 2.56%
The Vanguard Group, Inc. 60,977,378 2.39%
Norges Bank Investment Management 54,515,438 2.14%
Capital Research & Management Co. (Global Investors) 46,691,959 1.83%
UBS AG (Investment Management) 39,952,895 1.57%
Wellington Management Co. LLP 35,584,750 1.40%
BlackRock Fund Advisors 30,642,556 1.20%
Capital Research & Management Co. (World Investors) 27,422,351 1.08%
Holdings
NameEquities%Valuation
Novartis India Limited (NOIN) 17,450,68070.7%180,043,377 USD
Novartis India Ltd (500672) 17,450,68070.7%180,043,377 USD
Arrowhead Pharmaceuticals Inc (ARWR) 3,321,3833.60%41,251,577 USD
Mereo BioPharma Group plc 13,887,00019.5%31,924,130 USD
GenSight Biologics (SIGHT) 3,521,77414.2%13,406,302 USD
Aerpio Pharmaceuticals Inc (ARPO) 5,800,25014.3%9,860,425 USD
Oxurion (OXUR) 2,177,2265.69%9,009,797 USD
Aduro BioTech Inc (ADRO) 3,170,5283.99%8,370,194 USD
XOMA Corp (XOMA) 539,1316.21%6,820,007 USD
BioLineRX Ltd. 5,000,0004.35%2,185,050 USD
Markets and indexes
- SIX Swiss Exchange
- Domestic Standard
- FTSE Eurotop 100 / Low Carbon 100 Europe, SMI, Stoxx Europe 50, Stoxx Global 200
Stock Exchange Codes
- Bloomberg Code :  
- Reuters Code :  NOVN.S
- Datastream Code :  S:NOVS
Company contact information
Novartis
35 Lichtstrasse
CH-4002 Basel, Basel-Stadt
Switzerland

Phone : +41 61 324 79 44
Fax : +41 61 324 8001
Internet : http://www.novartis.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Novartis
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
NOVARTIS17.97%204 985
JOHNSON & JOHNSON2.48%344 675
ROCHE HOLDING LTD.12.16%238 287
MERCK AND COMPANY12.09%219 296
PFIZER-19.40%191 430
AMGEN4.37%121 841
NOVO NORDISK AS15.68%121 415
ASTRAZENECA23.77%115 885
SANOFI1.85%106 825
ELI LILLY AND COMPANY-2.76%101 622
GLAXOSMITHKLINE11.75%100 208
ABBVIE-27.96%98 186
BRISTOL-MYERS SQUIBB COMPANY-8.70%77 912
BAYER AG8.98%68 413
CELGENE CORPORATION48.63%67 515
TAKEDA PHARMACEUTICAL CO LTD-0.99%52 512
ALLERGAN PLC19.04%52 193
JIANGSU HENGRUI MEDICINE CO.36.42%45 076
DAIICHI SANKYO COMPANY, LIMITED111.45%44 107
CHUGAI PHARMACEUTICAL CO LTD20.87%38 439
ASTELLAS PHARMA INC5.29%25 777
Connections : Novartis
Weill Cornell Graduate School of Medical Sciences
International Federation of Pharmaceutical Manufacturers
Verily Life Sciences LLC
Simmons College (Massachusetts)
US Department of State (District of columbia)
SIX Swiss Exchange AG
National Academy of Medicine of United States
Harvard Business School
T-Mobile USA, Inc.
Novartis Institutes for Biomedical Research, Inc.
Novartis, Inc.
Novartis Pharma KK
Novartis Vaccines & Diagnostics, Inc.
American Academy of Arts & Sciences
Denzler & Partners
Jan Autos Holding SA
The Association for Research in Vision & Ophthalmology
The Rockefeller Foundation
Tear Film & Ocular Surface Society
The Brookings Institution
University of Illinois
American Accounting Association
Novartis Institute For Functional Genomics, Inc.
Banque Privée BCP (Suisse) SA
Institute of Management Accountants, Inc.
Chicago Medical Society Foundation
Raymond Weil SA
Chicago Ophthalmological Society
HSBC Private Banking Holdings (Suisse) SA
Verb Surgical, Inc.
Socotab Frana SA
American Ophthalmological Society
Generale Beaulieu Holding SA
Cold Spring Harbor Laboratory, Inc.
AP Møller Finance SA
National Academy of Sciences
Burberry Suisse SA
Oric Pharmaceuticals, Inc.